MENICHELLI, DANILO
 Distribuzione geografica
Continente #
NA - Nord America 1.598
EU - Europa 676
AS - Asia 151
AF - Africa 37
OC - Oceania 1
SA - Sud America 1
Totale 2.464
Nazione #
US - Stati Uniti d'America 1.580
IT - Italia 356
SE - Svezia 82
IN - India 80
AT - Austria 55
CN - Cina 33
SG - Singapore 30
TG - Togo 30
FI - Finlandia 26
GB - Regno Unito 22
DE - Germania 21
RO - Romania 20
BG - Bulgaria 19
IE - Irlanda 18
CA - Canada 16
UA - Ucraina 14
FR - Francia 12
ES - Italia 5
NL - Olanda 4
BE - Belgio 3
GR - Grecia 3
MK - Macedonia 3
PH - Filippine 3
PL - Polonia 3
RU - Federazione Russa 3
ZA - Sudafrica 3
DZ - Algeria 2
EE - Estonia 2
JP - Giappone 2
MX - Messico 2
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MY - Malesia 1
PT - Portogallo 1
SC - Seychelles 1
TR - Turchia 1
Totale 2.464
Città #
Fairfield 280
Ashburn 135
Chandler 130
Seattle 118
Houston 117
Rome 104
Wilmington 104
Woodbridge 95
Cambridge 81
San Paolo di Civitate 78
Princeton 51
Vienna 46
Ann Arbor 40
Lawrence 39
Millbury 38
San Diego 34
Lomé 30
Dearborn 24
Helsinki 21
New York 19
Sofia 19
Dublin 18
Beijing 17
Fremont 17
Plano 14
Boston 13
Singapore 12
Andover 10
Toronto 10
Milan 9
Pescara 8
Florence 7
Hyderabad 7
Norwalk 7
Phoenix 6
London 5
Salerno 5
Bremen 4
Denver 4
Los Angeles 4
Madrid 4
Naples 4
Perugia 4
Pordenone 4
Saint Etienne 4
Alzate Brianza 3
Brussels 3
Edinburgh 3
Frankfurt am Main 3
Hefei 3
Jacksonville 3
Manchester 3
Montreal 3
Redwood City 3
Southend 3
Tanza 3
Trieste 3
Algiers 2
Alimos 2
Aubusson 2
Bacoli 2
Bari 2
Boardman 2
Bolzano Vicentino 2
Bonndorf 2
Brescia 2
Bühl 2
Chicago 2
Chieti 2
Chongqing 2
Des Moines 2
Durban 2
Galatina 2
Genazzano 2
Genoa 2
Kilburn 2
Lerma 2
Liverpool 2
Mexico City 2
Miami 2
Nanjing 2
Nice 2
Nuremberg 2
Ottawa 2
Prilep 2
Provo 2
Putignano 2
Rovereto 2
San Mateo 2
St Petersburg 2
Sëlva 2
Tallinn 2
Treviso 2
Turin 2
Uden 2
Vercelli 2
Alessandria 1
Alexandria 1
Athens 1
Bad Bellingen 1
Totale 1.918
Nome #
Relationship of PCSK9 and urinary thromboxane excretion to cardiovascular events in patients with atrial fibrillation 120
Is there an interplay between adherence to mediterranean diet, antioxidant status, and vascular disease in atrial fibrillation patients? 101
Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet 99
Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation. a post-hoc analysis from the ATHERO-AF cohort 98
Features of severe COVID-19. a systematic review and meta-analysis 94
Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation 92
Adherence to the 'atrial fibrillation better care' pathway in patients with atrial fibrillation. impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients 90
Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding 86
Statins and major adverse limb events in patients with peripheral artery disease. a systematic review and meta-analysis 81
Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review 73
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants 71
Hazelnut and cocoa spread improves flow-mediated dilatation in smokers 66
Cancer-specific ischemic complications in elderly Patients with atrial fibrillation. data from the prospective ATHERO-AF study 66
Integrated care management of patients with atrial fibrillation and risk of cardiovascular events. the abc (atrial fibrillation better care) pathway in the ATHERO-AF study cohort 65
Oxidative stress and cardiovascular disease: New insights 64
Tailored practical management of patients with atrial fibrillation. a risk factor-based approach 64
Silybin and metabolic disorders 62
Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation 60
Update and unmet needs on the use of nonvitamin k oral anticoagulants for stroke prevention in patients with atrial fibrillation 56
Direct oral anticoagulants and advanced liver disease. a systematic review and meta-analysis 53
The atrial fibrillation better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. the ATHERO-AF study 53
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes. insights from the multicenter START-ANTIPLATELET registry 51
Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. a prospective multicenter cohort study 51
Seronegative antiphospholipid syndrome: Refining the value of “non-criteria” antibodies for diagnosis and clinical management 50
Relation of atrial fibrillation to angiographic characteristics and coronary artery disease severity in patients undergoing percutaneous coronary intervention 49
Comparison of anticoagulation quality between acenocoumarol and warfarin in patients with mechanical prosthetic heart valves. insights from the nationwide plectrum study 47
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis 46
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta-Analysis 45
Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation. a network metanalysis on 605,771 patients 45
Fibrosis-4 (FIB-4) index and mortality in COVID-19 patients admitted to the emergency department 45
Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. the nationwide PLECTRUM study 44
Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation. a multicentre cohort study 44
Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. a prospective multicenter cohort study 42
Multiple arterial thrombosis in seronegative antiphospholipid syndrome. need for new diagnostic criteria 41
null 41
Cancer and atrial fibrillation. epidemiology, mechanisms, and anticoagulation treatment 38
Serum albumin and risk of cardiovascular events in primary and secondary prevention: a systematic review of observational studies and Bayesian meta-regression analysis 35
Sex-based difference in anticoagulated patients with mechanical prosthetic heart valves and long-term mortality risk 34
Long-term risk of major adverse cardiac events in atrial fibrillation patients on direct oral anticoagulants 32
A comprehensive review of risk factors for venous thromboembolism. from epidemiology to pathophysiology 29
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes. from the START antiplatelet registry 27
Use of direct oral anticoagulants in patients with antiphospholipid syndrome. a systematic review and comparison of the international guidelines 27
Circulating lipopolysaccharides and impaired antioxidant status in patients with atrial fibrillation. data from the athero-af study 26
Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer. a nationwide cohort study 25
Mediterranean diet: a tool to break the relationship of atrial fibrillation with the metabolic syndrome and non-alcoholic fatty liver disease 22
A systematic review and a meta-analysis comparing prophylactic and therapeutic low molecular weight heparins for mortality reduction in 32,688 COVID-19 patients 21
Minimizing drug-drug interactions between dabigatran and levetiracetam through clinical management. a case report 20
How to treat patients with splanchnic vein thrombosis. recent advances 20
Clinical phenotypes of atrial fibrillation and mortality risk-a cluster analysis from the nationwide italian START registry 19
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF). a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study 19
Bleeding and thrombotic events in atrial fibrillation patients with cancer. a systematic review and meta-analysis 16
Bleeding and mortality risk in patients implanted with mechanical prosthetic heart valves with and without thrombocytopenia. insights from the nationwide PLECTRUM registry 16
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes. insights from the START-ANTIPLATELET registry 13
Factor V Leiden, prothrombin, MTHFR, and PAI-1 gene polymorphisms in patients with arterial disease. A comprehensive systematic-review and meta-analysis 9
Association of proprotein convertase subtilisin/kexin type 9 (PCSK9) levels with abnormally high ankle-brachial index in atrial fibrillation 9
Risk of venous thromboembolism in autoimmune diseases. A comprehensive review 9
Venous Thromboembolism in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis of 4,170,027 Patients 4
Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis 4
Statins under-treatment and mortality in patients with atrial fibrillation. insights from the nationwide START registry 4
Gut barrier dysfunction and endotoxemia in heart failure: A dangerous connubium? 3
Renin‐angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. insights from the nationwide START registry 3
Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses 3
Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation 2
Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes 1
Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 1
Totale 2.746
Categoria #
all - tutte 8.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019116 0 0 0 0 0 0 0 0 0 8 25 83
2019/2020395 41 13 11 10 37 53 55 39 40 47 34 15
2020/2021503 31 17 56 42 4 22 50 13 57 97 79 35
2021/2022578 20 20 47 22 69 39 12 48 36 35 113 117
2022/2023723 109 181 51 66 59 62 9 68 42 18 50 8
2023/2024372 14 55 24 37 45 57 13 50 28 49 0 0
Totale 2.746